C&EN’s Year in Pharma 2022: Genetic therapies kept moving from lab to clinic By / On December 2, 2022 / At 1:55 pm / In Chemical world 27 Views A flurry of advances in clinical trials was tempered by problems and slowdowns Post navigation Prev PostPeriodic Graphics: Fuels for space travel Next PostC&EN’s Year in Pharma 2022: The roller-coaster ride continued for Alzheimer’s drug candidates You May Also Like New Jersey sues Dow Chemical and others over 1,4-dioxane pollution On March 28, 2023 | In Chemical world Sentencing delayed again for Harvard’s former chemistry head On March 28, 2023 | In Chemical world Meeting the tigers of the lab On March 28, 2023 | In Chemical world